Irving, TX, May  12, 2026  (GLOBE NEWSWIRE) --  Breeze Acquisition Corp. II (the &#34;Company&#34;) announced today that it priced its initial public offering of 12,500,000 units at a price to the public of $10.00 per unit. The

BREZ

Breeze Acquisition Corp. II Announces Pricing of $125,000,000 Initial Public Offering

Breeze Acquisition Corp. II IPO Priced at $10.00 per Unit

<section class="insight" data-version="1">
  <section data-block="information">
    <h3>Information</h3>
    <p>Irving, TX, May  12, 2026  (GLOBE NEWSWIRE) --  Breeze Acquisition Corp. II (the &amp;#34;Company&amp;#34;) announced today that it priced its initial public offering of 12,500,000 units at a price to the public of $10.00 per unit. The</p>
  </section>

  <section data-block="ai-summary-paragraph">
    <h3>AI Summary</h3>
    <p>Breeze Acquisition Corp. II has priced its initial public offering at $10.00 per unit, starting on Nasdaq under symbol &#039;BREZU.&#039; The proceeds will be utilized for strategic acquisitions, indicating active growth potential, particularly in the tech and healthcare sectors.</p>
  </section>

  <section data-block="ai-summary-bullets">
    <h3>Key Points</h3>
    <ul><li>Breeze Acquisition Corp. II priced IPO at $10.00 per unit.</li><li>Unit trading on Nasdaq expected to start May 13, 2026.</li><li>Each unit comprises one share and one right for further shares.</li><li>The offering aims to raise funds for strategic acquisitions.</li><li>IB Capital LLC and I-Bankers Securities are managing the IPO.</li></ul>
  </section>

  <section data-block="companies-mentioned">
    <h3>Companies Mentioned</h3>
    <ul><li><strong>IB Capital LLC (N/A)</strong>: Acting as a book-running manager for the IPO.</li><li><strong>I-Bankers Securities, Inc. (N/A)</strong>: Co-managing the IPO alongside IB Capital LLC.</li></ul>
  </section>

  <section data-block="category">
    <h3>Corporate Developments</h3>
    <p>This news fits under &#039;Corporate Developments&#039; as it involves Breeze&#039;s IPO process, essential for funding future investments. Strong initial investor interest and strategic focus areas signify potential growth.</p>
  </section>

  <section data-block="market-moving">
    <h3>Market-Moving</h3>
    <ul><li>The IPO pricing at $10.00 may attract significant initial investor interest.</li><li>The ability of BREZ to successfully complete acquisitions could drive future price appreciation.</li><li>Trading mandate in high-tech sectors may enhance market reputation and valuation.</li><li>Possible over-allotment option by underwriters suggests strong initial demand.</li></ul>
  </section>

  <section data-block="key-facts">
    <h3>Key Facts</h3>
    <ul><li>12,500,000 units offered at $10.00 each, total potential raise of $125 million.</li><li>Initial public offering expected to close around May 14, 2026.</li><li>Units separate into shares (BREZ) and rights to additional shares (BREZR).</li><li>Underwriters granted a 45-day over-allotment option for up to 1,875,000 units.</li><li>Breeze Acquisition Corp. II targets sectors like healthcare and technology.</li></ul>
  </section>

  <section data-block="trading-thesis">
    <h3>Trading Thesis</h3>
    <p>Invest in BREZ for potential short-term gains as IPO trading begins.</p>
  </section>
</section>


<link type="text/css" rel="stylesheet" href="https://www.globenewswire.com/styles/gnw_nitf.css"></link><p align="justify"><strong>Irving, TX, May  12, 2026  (GLOBE NEWSWIRE) -- </strong> Breeze Acquisition Corp. II (the "Company") announced today that it priced its initial public offering of 12,500,000 units at a price to the public of $10.00 per unit. The units are expected to commence trading on May 13, 2026 on the Nasdaq Global Market under the symbol "BREZU."</p>  <p align="justify">Each unit consists of one ordinary share and one right. Each right entitles the holder to receive one-fifth (1/5) of one ordinary share upon the consummation of an initial business combination. Once the securities comprising the units begin separate trading, the ordinary shares and rights are expected to be traded on the Nasdaq Global Market under the symbols "BREZ" and "BREZR," respectively.</p>  <p align="justify">IB Capital LLC and I-Bankers Securities, Inc. are acting as book-running managers of the offering. The underwriters have been granted a 45-day option to purchase up to an additional 1,875,000 units offered by the Company to cover over-allotments, if any. The offering is expected to close on or about May 14, 2026, subject to customary closing conditions.</p>  <p align="justify">The offering is being made only by means of a prospectus. When available, copies of the prospectus related to this offering may be obtained from IB Capital LLC at 51 Kings Court St; PH, San Juan, PR 00911.</p>  <p align="justify">A registration statement relating to the securities was declared effective by the Securities and Exchange Commission ("SEC") on May 12, 2026. This press release shall not constitute an offer to sell or the solicitation of an offer to buy any securities, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.</p>  <p align="justify"><b>About Breeze Acquisition Corp. II</b></p>  <p align="justify">Breeze Acquisition Corp. II is a blank check company incorporated in the Cayman Islands for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or other similar business combination with one or more businesses or entities. The Company intends to focus its initial search on target businesses with global operations and differentiated technology or capabilities, particularly in healthcare, biotechnology, advanced manufacturing, robotics, artificial intelligence, and related sectors. The net proceeds of the offering will be used to fund such business combination.</p>  <p align="justify"><b>Forward-Looking Statements </b></p>  <p align="justify">This press release includes forward-looking statements that involve risks and uncertainties. Forward-looking statements are statements that are not historical facts. Such forward-looking statements, including with respect to the closing of the initial public offering and the anticipated use of the net proceeds thereof, are subject to risks and uncertainties, which could cause actual results to differ from the forward-looking statements, including those set forth in the risk factors section of the prospectus used in connection with the Company's initial public offering filed with the SEC, copies of which are available on the SEC's website, at <a href="https://www.globenewswire.com/Tracker?data=-QnVE4ICk0TCNrDhogYDd_-R4iBbMtw_cu1kTRWYmDEOpZi0lIvFJ2hR6Ca655InL4ZyvWFSIy-QVN3oNDGPsw==" rel="nofollow" target="_blank">www.sec.gov</a>. No assurance can be given the offering discussed above will be completed on the terms described, or at all, or the net proceeds of the offering will be used as indicated. The Company expressly disclaims any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements contained herein to reflect any change in the Company's expectations with respect thereto or any change in events, conditions or circumstances on which any statement is based, except as required by law.</p>  <p align="justify"><b>Contact:</b></p>  <p align="justify"><b>J. Douglas Ramsey</b><br></br>Breeze Acquisition Corp. II<br></br>955 W. John Carpenter Fwy<br></br>Suite 100-929<br></br>Irving, TX 75039<br></br>(888) 273-9001</p> <img alt="" class="__GNW8366DE3E__IMG" src="https://www.globenewswire.com/newsroom/ti?nf=OTcxOTEyOCM3NjAwMTQxIzUwMDE2MjQ2Ng=="></img> <br></br><img alt="" src="https://ml.globenewswire.com/media/NDYzOGJjOWEtMWRhZi00NTc1LTkwMDktNzJiZDA2YWNlYTViLTUwMDE2MjQ2Ni0yMDI2LTA1LTEzLWVu/tiny/Breeze-Acquisition-Corp-II.png" referrerpolicy="no-referrer-when-downgrade"></img>

Breeze Acquisition Corp. II has priced its initial public offering at $10.00 per unit, starting on Nasdaq under symbol 'BREZU.' The proceeds will be utilized for strategic acquisitions, indicating active growth potential, particularly in the tech and healthcare sectors.

Breeze Acquisition Corp. II Announces Pricing of $125,000,000 Initial Public Offering

AI Summary

Sentiment Rationale

Trading Thesis

Market-Moving

Key Facts

Companies Mentioned

Corporate Developments

Related News